JAN (NYSE:JAN) Price Target Raised to $34.00
by Mitch Edgeman · The Markets DailyJAN (NYSE:JAN – Get Free Report) had its price target raised by investment analysts at Cantor Fitzgerald from $30.00 to $34.00 in a report released on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective suggests a potential upside of 11.52% from the stock’s previous close.
A number of other research analysts have also issued reports on JAN. Wall Street Zen lowered shares of JAN from a “hold” rating to a “sell” rating in a report on Saturday, June 6th. Royal Bank Of Canada raised their price target on shares of JAN from $27.00 to $30.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. The Goldman Sachs Group began coverage on shares of JAN in a report on Tuesday, April 14th. They set a “neutral” rating and a $27.00 price target on the stock. Morgan Stanley assumed coverage on shares of JAN in a research note on Tuesday, April 14th. They issued an “overweight” rating and a $28.00 price objective on the stock. Finally, JPMorgan Chase & Co. began coverage on JAN in a report on Tuesday, April 14th. They issued an “overweight” rating and a $26.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, JAN presently has a consensus rating of “Buy” and a consensus price target of $29.85.
Read Our Latest Stock Analysis on JAN
JAN Trading Up 1.9%
Shares of JAN opened at $30.49 on Thursday. JAN has a one year low of $22.76 and a one year high of $32.83. The firm has a market capitalization of $8.02 billion, a P/E ratio of -609.74 and a beta of 2.16. The company’s 50 day moving average price is $28.25.
JAN (NYSE:JAN – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $0.23 EPS for the quarter, hitting analysts’ consensus estimates of $0.23. The company had revenue of $200.35 million during the quarter, compared to the consensus estimate of $157.96 million.
Key JAN News
Here are the key news stories impacting JAN this week:
- Positive Sentiment: Janus Living reported quarterly EPS of $0.24, ahead of the $0.23 consensus estimate. Revenue rose 45.4% year over year to $216.46 million, exceeding expectations of $203.32 million. Janus Living quarterly earnings report
- Positive Sentiment: Management emphasized a debt-free balance sheet and growth initiatives, which may support investor confidence by reducing financial risk and providing flexibility to invest in expansion. Janus Living boosts outlook on debt-free growth
- Positive Sentiment: The company’s latest revenue performance materially exceeded the prior consensus forecast, reinforcing the narrative of accelerating demand and operational momentum.
- Neutral Sentiment: Janus Living issued fiscal 2026 EPS guidance of $0.95 to $0.98, compared with the $0.97 analyst consensus. The range is broadly in line with expectations, limiting the potential for a major forecast-driven repricing.
- Neutral Sentiment: Investors are likely to focus on whether the company can sustain its rapid revenue growth while preserving margins and executing its expansion plans without taking on debt. Janus Living Q2 2026 earnings call transcript
About JAN
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Further Reading
- Five stocks we like better than JAN
- These Outperforming Giants Are Boosting Dividends in 2026, With Yields of Up to 6.6%
- Why Analysts Are Bullish on a Stock That’s Down 20%
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks